Table 3 Galectin-3, HBME-1 and CK19 immunolabelling in the variants of PTC
From: Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential
Variant | FVPTC | WDT-UMP lesion | Papillary microCa | Metastatic papillary Ca |
|---|---|---|---|---|
Galectin-3 | 08/13 | 04/13 | 09/13 | 13/13 |
HBME-1 | 10/13 | 10/13 | 12/13 | 13/13 |
CK19 | 11/13 | 11/13 | 11/13 | 13/13 |